Cargando…
Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
BACKGROUND: A large number of studies have provided a variety of heart failure management program (HF-MP) intervention modes. It is generally believed that HF-MP is effective, but the question of which type of program works best, what level of support is needed for an intervention to be effective, a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972626/ https://www.ncbi.nlm.nih.gov/pubmed/36855208 http://dx.doi.org/10.1186/s13643-023-02183-8 |
_version_ | 1784898361586876416 |
---|---|
author | Duan, Yongjie Li, Zongren Zhong, Qin Rao, Chongyou Hua, Yun Wu, Rilige Dong, Jing Li, Da Wang, Wenjun He, Kunlun |
author_facet | Duan, Yongjie Li, Zongren Zhong, Qin Rao, Chongyou Hua, Yun Wu, Rilige Dong, Jing Li, Da Wang, Wenjun He, Kunlun |
author_sort | Duan, Yongjie |
collection | PubMed |
description | BACKGROUND: A large number of studies have provided a variety of heart failure management program (HF-MP) intervention modes. It is generally believed that HF-MP is effective, but the question of which type of program works best, what level of support is needed for an intervention to be effective, and whether different subgroups of patients are best served by different types of programs is still confusing. METHODS: This study will search for published and unpublished randomized clinical trials in English examining HF-MP interventions in comparison with usual care. MEDLINE, Medlin In-Process and Non-Indexed, CENTRAL, CINAHL, EMBASE, and PsycINFO will be the databases. We will calibrate our eligibility criteria among the team. Each literature will be screened by at least two reviewers. Conflicts will be resolved through team discussion. A similar process will be used for data abstraction and quality appraisal. The results will be synthesized descriptively, and a network meta-analysis will be conducted if the studies are deemed methodologically, clinically, and statistically acceptable (e.g., I(2) < 50%). Moreover, potential moderators of efficacy will be analyzed using a meta-regression. DISCUSSION: This study will reduce the clinical heterogeneity and statistical heterogeneity of review and meta-analysis through a more scientific classification method to determine the most effective HF-MP in different subgroups of heart failure patients with different human resource investments and different intervention methods, providing high-quality evidence and guidance for clinical practice. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021258521 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-023-02183-8. |
format | Online Article Text |
id | pubmed-9972626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99726262023-03-01 Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis Duan, Yongjie Li, Zongren Zhong, Qin Rao, Chongyou Hua, Yun Wu, Rilige Dong, Jing Li, Da Wang, Wenjun He, Kunlun Syst Rev Protocol BACKGROUND: A large number of studies have provided a variety of heart failure management program (HF-MP) intervention modes. It is generally believed that HF-MP is effective, but the question of which type of program works best, what level of support is needed for an intervention to be effective, and whether different subgroups of patients are best served by different types of programs is still confusing. METHODS: This study will search for published and unpublished randomized clinical trials in English examining HF-MP interventions in comparison with usual care. MEDLINE, Medlin In-Process and Non-Indexed, CENTRAL, CINAHL, EMBASE, and PsycINFO will be the databases. We will calibrate our eligibility criteria among the team. Each literature will be screened by at least two reviewers. Conflicts will be resolved through team discussion. A similar process will be used for data abstraction and quality appraisal. The results will be synthesized descriptively, and a network meta-analysis will be conducted if the studies are deemed methodologically, clinically, and statistically acceptable (e.g., I(2) < 50%). Moreover, potential moderators of efficacy will be analyzed using a meta-regression. DISCUSSION: This study will reduce the clinical heterogeneity and statistical heterogeneity of review and meta-analysis through a more scientific classification method to determine the most effective HF-MP in different subgroups of heart failure patients with different human resource investments and different intervention methods, providing high-quality evidence and guidance for clinical practice. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021258521 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-023-02183-8. BioMed Central 2023-02-28 /pmc/articles/PMC9972626/ /pubmed/36855208 http://dx.doi.org/10.1186/s13643-023-02183-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Protocol Duan, Yongjie Li, Zongren Zhong, Qin Rao, Chongyou Hua, Yun Wu, Rilige Dong, Jing Li, Da Wang, Wenjun He, Kunlun Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis |
title | Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis |
title_full | Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis |
title_fullStr | Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis |
title_full_unstemmed | Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis |
title_short | Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis |
title_sort | efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972626/ https://www.ncbi.nlm.nih.gov/pubmed/36855208 http://dx.doi.org/10.1186/s13643-023-02183-8 |
work_keys_str_mv | AT duanyongjie efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT lizongren efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT zhongqin efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT raochongyou efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT huayun efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT wurilige efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT dongjing efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT lida efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT wangwenjun efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis AT hekunlun efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis |